News | July 23, 2007

AONE Receives Second Robert Wood Johnson Foundation Grant to Improve Patient Care Delivery

July 24, 2007 — The American Organization of Nurse Executives (AONE) announced the receipt of a second grant from the Robert Wood Johnson Foundation (RWJF) to identify, develop and disseminate a set of practical, easy-to-use tools that will help hospitals redesign delivery of care to improve the quality and safety of patient care on medical and surgical units.

This supplemental grant of more than $600,000 brings the grant total for the “Disseminating Transforming Care at the Beside (TCAB)” project to over $1.5 million. The grant will allow AONE to share insights from the TCAB project, a multi-year collaborative between RWJF and the Institute for Healthcare Improvement, with 68 hospitals nationwide. The original grant received in January 2007 was to support 50 hospitals and the new funds will support the additional 18 hospitals and other project-related activities.

All participating hospitals will be taught the basics of the TCAB innovation process with a focus on nurse managers and team training. The program engages nurses to develop interventions and design new processes that improve care and leads to better staff morale.

“By assisting us with this additional funding, the Foundation continues to demonstrate its support of AONE’s leadership in transforming the delivery of patient care,” said Linda Q. Everett, PhD, RN, CNAA, BC, FAAN, president of AONE. “The additional funding has enabled us to achieve our goal of sharing the important lessons learned from TCAB with more hospitals.”

“Nurses are professionals who traditionally aren’t asked their opinion on how to fix problems or improve care,” said Sue Hassmiller, PhD, RN, FAAN, senior program officer at RWJF. “TCAB creates an environment where nurses are engaged to think creatively about making changes, share ideas and be part of the process that improves patient safety and satisfaction.”

At this time, all 68 hospitals have been selected.

For more information: www.aone.org

Related Content

Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...
Bay Labs Announces New Echocardiography Guidance Software Data at ASE 2019 Scientific Sessions
News | Cardiovascular Ultrasound | June 20, 2019
Bay Labs announced that new data on the company’s first-of-its-kind deep learning investigational guidance software...
LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction
News | Cardiovascular Ultrasound | June 19, 2019
DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's...
New Data Demonstrates Safety Profile of GammaTile Therapy for Various Brain Tumors
News | Brachytherapy Systems | June 18, 2019
GT Medical Technologies Inc. announced the presentation of clinical data from a prospective study of GammaTile Therapy...
Black Men Less Likely to Adopt Active Surveillance for Low-Risk Prostate Cancer
News | Prostate Cancer | June 17, 2019
A new study reveals black men are less likely than white men to adopt an active surveillance strategy for their...
AI Biomarker Demonstrates High Predictive Power for Lung Cancer Immunotherapy
News | Artificial Intelligence | May 31, 2019
Lunit announced an abstract presentation of its artificial intelligence (AI) precision medicine research portfolio at...
Dynamic Digital Radiography Used to Assess Undifferentiated Dyspnea
News | Digital Radiography (DR) | May 29, 2019
A clinical study presented at the American Thoracic Society (ATS) 2019 annual meeting, May 17-22 in Dallas, described...
Leica Biosystems Receives FDA Clearance for Aperio AT2 DX Digital Pathology System
Technology | Digital Pathology | May 29, 2019
Leica Biosystems has received clearance from the U.S. Food and Drug Administration (FDA) to market its Aperio AT2 DX...
New Blood Test Detects Colorectal Cancer Recurrence Up to 16.5 Months Earlier
News | Oncology Diagnostics | May 28, 2019
A new clinical study shows that Natera's Signatera test identified colorectal cancer recurrence up to 16.5 months...
Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...